Treatment of silent myocardial ischemia.
Long-term studies regarding the effect of treatment on prognosis are lacking, but the adverse implications suggested for silent ischemia support aggressive management. Treatment of silent ischemic episodes is possible utilizing a large variety of agents. Optimal detection and quantitation methods are still being developed, but guidelines for treatment should be similar to those for treatment of symptomatic ischemia.